arrow
返回
Yong Jiang 封面图

Yong Jiang (Yong Jiang)

china national offshore oil corporation (cnooc)

51H指数
467论文数
9.8K被引数
收录论文 168
发表时间
err分享
err收藏
(+)/(-)-Corydecumbenpines A and B, two pairs of dimeric phthalide-benzophenanthridine alkaloids with cytotoxicity from Corydalis decumbens
err2025-05-01
err0
PREAI
errGao, Peng; Wang, Yu-Qi; Yuan, Shuo; Wang, Yan-Hang; Zhao, Ming-Bo; Zeng, Ke-Wu; Jiang, Yong; Zhang, Qing-Ying; Tu, Peng-Fei
err分享
err收藏
Experimental analysis and theoretical calculation of local bearing capacity of lightweight UHPC anchorage zone
err2024-12-01
err0
PREAI
errHu, Yuqing; Zhu, Qi; Jiang, Yong; Zhang, Ning; Wang, Jingquan
err分享
err收藏
Obtusin ameliorates diabetic retinopathy by inhibiting oxidative stress and inflammation
err2024-11-03
err0
PREAI
errXu, Jingyi; Shen, Rongjing; Qian, Mengting; Ning, Luying; Zhang, Xinyu; Xie, Bingqing; Jiang, Yong; Zhou, Zhengjun; Dong, Wei
err分享
err收藏
Preparation, structure, and property evolution of transparent germanate glass-ceramics based on a new strategy: One-step heat treatment around Tg
err2024-11-01
err1
PREAI
errLin, Xiangtao; Liang, Haozhang; Jiang, Xingxing; Liu, Taoyong; Zhou, Ziyou; Luo, Zhiwei; Lu, Anxian; Jiang, Yong
err分享
err收藏
NO inhibitory constituents from Glycosmis craibii var. glabra
err2024-11-01
err0
PREAI
errChen, Hongwei; Ding, Meng; Lin, Jun; Yuan, Shuo; Zeng, Kewu; Tu, Pengfei; Jiang, Yong
err分享
err收藏
Discovery and development of IMP1734 (EIK1003), a potent and selective PARP1 inhibitor
err2024-10-01
err0
PREAI
errCai, S. X.; Ma, N.; Wang, X.; Zhao, Y.; Zhou, R.; Jiang, Y.; Chen, M.; Tian, Y. E.; Krishnan, S.; Dumble, M.
err分享
err收藏
The dynamics beamline at SSRFSSRF的动态光束线
err2024-08-30
err1
PREAI
errLiu, Zhen; Wang, Li-Hua; Jiang, Yong; Tong, Ya-Jun; Zhu, Hua-Chun; Ji, Te; Chen, Min; Jiang, Zheng; Wei, Xiang-Jun
err分享
err收藏
Lactylation of histone by BRD4 regulates astrocyte polarization after experimental subarachnoid hemorrhage
err2024-07-30
err2
errOAAI
errZhang, Fan; Zhou, Jian; Lu, Peng; Zhang, Xianhui; Yang, Lei; Wu, Jinpeng; Zhang, Lihan; Zhang, Lifang; Pang, Jinwei; Xie, Huangfan; Xie, Bingqing; Jiang, Yong; Peng, Jianhua
err分享
err收藏
Patient-reported outcomes for the phase 3 FURLONG study of furmonertinib versus ge fi tinib as fi rst-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer
err2024-07-01
err1
errOAAI
errShi, Yuankai; Chen, Gongyan; Wang, Xiang; Liu, Yunpeng; Wu, Lin; Hao, Yanrong; Liu, Chunling; Zhu, Shuyang; Zhang, Xiaodong; Li, Yuping; Liu, Jiwei; Cao, Lejie; Cheng, Ying; Zhao, Hui; Zhang, Shucai; Zang, Aimin; Cui, Jiuwei; Feng, Jian; Yang, Nong; Hu, Jie; Liu, Fei; Jiang, Yong; Ge, Nan
err分享
err收藏
FURTHER: A global study to evaluate furmonertinib in patients with EGFR mutant NSCLC including uncommon EGFR mutations
err2024-04-05
err0
PREAI
errLe, Xiuning; Spira, Alexander; Gadgeel, Shirish; Yu, Yan; Zhao, Yanqiu; Cheng, Ying; Riess, Jonathan; Juan-Vidal, Oscar; Gao, Bo; Yoh, Kiyotaka; Forster, Martin; Kitazono, Satoru; Hayashi, Hidetoshi; Planchard, David; Jiang, Yong; Huang, Jack; Baio, Nichole; Kowanetz, Marcin; Wang, Shirley; Leung, William; Hsu, Jerry Y.; Wang, Jie
err分享
err收藏